Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study.
Juan Pablo AlderuccioWeiyun Z AiJohn RadfordMelhem SolhKirit M ArdeshnaMatthew A LunningBrian T HessPier L ZinzaniAnastasios StathisCarmelo Carlo-StellaMehdi HamadaniBrad S KahlDavid UngarTurk KilavuzEric YuYajuan QinPaolo F CaimiPublished in: Blood advances (2022)